SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales moved up 40.39% to Rs. 3638.47 millions for the March 2022 quarter as compared to Rs. 2591.65 millions during the year-ago period.Net Profit witnessed a 248.27% growth almost the double from Rs. 644.51 millions to Rs. 2244.64  millions  of same quarter last year.OP of the company witnessed a marginal growth to 2919.64 millions from 969.90 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 3638.47 2591.65 40.39 13202.22 10097.19 30.75 13202.22 10097.19 30.75
Other Income 1343.96 32.98 3975.08 1877.88 142.37 1219.01 1877.88 142.37 1219.01
PBIDT 2919.64 969.90 201.02 7677.76 4547.59 68.83 7677.76 4547.59 68.83
Interest 21.89 18.70 17.06 62.31 91.44 -31.86 62.31 91.44 -31.86
PBDT 2897.75 951.20 204.64 7615.45 4456.15 70.90 7615.45 4456.15 70.90
Depreciation 104.21 83.15 25.33 390.97 316.36 23.58 390.97 316.36 23.58
PBT 2793.54 868.05 221.82 7224.48 4139.79 74.51 7224.48 4139.79 74.51
TAX 548.90 223.54 145.55 1643.49 1053.32 56.03 1643.49 1053.32 56.03
Deferred Tax 34.10 40.07 -14.90 67.19 36.17 85.76 67.19 36.17 85.76
PAT 2244.64 644.51 248.27 5580.99 3086.47 80.82 5580.99 3086.47 80.82
Equity 254.57 254.57 0.00 254.57 254.57 0.00 254.57 254.57 0.00
PBIDTM(%) 80.24 37.42 114.42 58.16 45.04 29.12 58.16 45.04 29.12

Cohance Lifesciences Share Price

363.25 6.35 (1.78%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×